How many doses of MenACWY (Meningococcal Conjugate) vaccine does a 16-year-old need?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Meningococcal Vaccination Requirements for a 16-Year-Old

A 16-year-old needs one dose of MenACWY (Menquadfi) vaccine as a booster if they received their first dose before age 16, or a single primary dose if they have not been previously vaccinated. 1

MenACWY Vaccination Schedule

The Advisory Committee on Immunization Practices (ACIP) recommends the following schedule for MenACWY vaccination in adolescents:

  • Primary dose: Given at age 11-12 years
  • Booster dose: Given at age 16 years if the first dose was administered before the 16th birthday 1
  • Catch-up vaccination: If a teen hasn't received any MenACWY vaccine by age 16, they should receive a single dose

The booster dose is critical because protection from the primary dose wanes within 3-5 years after vaccination. Studies have shown that vaccine effectiveness decreases from 79% in the first year to 61% at 3-8 years post-vaccination 2.

MenB Vaccination Considerations

In addition to MenACWY, the CDC recommends that adolescents aged 16-23 years may also receive MenB vaccination based on shared clinical decision-making (with a preferred age of 16-18 years) 1, 3:

  • MenB-FHbp (Trumenba): 2 doses at 0 and 6 months for healthy adolescents
  • MenB-4C (Bexsero): 2 doses at least 1 month apart

However, MenB vaccination is not part of the routine adolescent immunization schedule like MenACWY is, and should be discussed individually with the healthcare provider.

Special Considerations

College Entry Requirements

If the 16-year-old will be attending college, it's important to note that:

  • College freshmen living in residence halls should have received at least one dose of MenACWY within 5 years before college entry 1
  • The preferred timing of the most recent dose is on or after the 16th birthday
  • If only one dose was administered before the 16th birthday, a booster dose should be administered before college enrollment

High-Risk Individuals

For 16-year-olds with certain risk factors (such as complement deficiency, asplenia, or HIV), additional doses or different schedules may be required 1.

Common Pitfalls to Avoid

  1. Confusing MenACWY and MenB vaccines: These protect against different serogroups and have different recommendations.

  2. Missing the booster dose: Failure to administer the booster dose at age 16 leaves adolescents vulnerable during their highest risk period.

  3. Vaccine brand interchangeability: While MenACWY vaccines (MenACWY-D, MenACWY-CRM, or MenACWY-TT) are interchangeable, MenB vaccines are not interchangeable and the same product must be used for all doses in a series 3.

  4. Overlooking college entry requirements: Many colleges require proof of MenACWY vaccination within 5 years of entry.

The 2020 ACIP guidelines clearly state that adolescents should receive a booster dose of MenACWY at age 16 if they received their first dose before their 16th birthday, ensuring protection during the period of increased risk through late adolescence and early adulthood 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Meningococcal B Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.